AgeneBio (@AgeneBio) profile picture

AgeneBio develops innovative therapeutics that prevent neurodegeneration and preserves cognitive function.

Baltimore, MD
Joined October 2014
AgeneBio founder Michela Gallagher to speak on emerging #Alzheimers therapies at @ASENT_Org 2018 Annual Meeting https://nitter.cf/t.co/XwxOQdd32l
2
AgeneBio founder Michela Gallagher to speak at 2018 @NIH #Alzheimers Research Summit on March 2 https://nitter.cf/t.co/ln1skbTpA3 #ADSummit18
2
AgeneBio receives NIH grant to initiate Phase 3 HOPE4MCI trial to treat MCI due to #Alzheimers disease https://nitter.cf/t.co/Y1quCNt6NY
2
7
AgeneBio receives up to $10M in NIH funding to advance program for mild cognitive impairment due to #alzheimers https://nitter.cf/t.co/EOQHvba9Ys
1
2
Thanks 2 @TheADDF 4 another grant--will fund GABA-A drug-discovery program to delay onset of #Alzheimers dementia https://nitter.cf/t.co/NDTzPbI63I
8
3
12
Our new corporate presentation is loaded on agenebio.com/investor-relati… #Alzheimers
1
CEO Jerry McLaughlin presenting today at 3:35pm in NYC @ Neuroscience BioPartnering & Investment Forum https://nitter.cf/t.co/ukeFtHp6NF #Alzheimers
Looking fwd 2 tomorrow's Neuroscience BioPartnering & Investment Forum CEO Jerry McLaughlin to present https://nitter.cf/t.co/ukeFtHp6NF #Alzheimers
CEO Jerry McLaughlin 2 present @ Neuroscience BioPartnering & Investment Forum https://nitter.cf/t.co/ukeFtHp6NF #Alzheimer #Phase3 #aMCI
Looking forward 2 @IAmBiotech CEO & Investor Conf our CEO on tap Feb 8 10:15am NYC https://nitter.cf/t.co/UbGCK8mSfU #alzheimers #phase3
AgeneBio CEO Jerry McLaughlin to present at @IAmBiotech CEO & Investor Conf Feb 8 10:15am NYC https://nitter.cf/t.co/UbGCK85hom #alzheimers #phase3
1
1
We welcome the distinguished Dr. Richard Mohs as our VP, Clinical Development for #Alzheimer's Phase3 HOPE4MCI trial https://nitter.cf/t.co/R0Ctn1kAe2
1
.@alzforum reviews our own Dr. Gallagher's CTAD session on new #Alzheimers Phase 3 #clinicaltrials https://nitter.cf/t.co/FKVbaGsGzW
1
AgeneBio CEO Jerry McLaughlin to present @ Future of Innovation in Medicine Conference @gatesfoundation https://nitter.cf/t.co/o1y9Mfva1A #Alzheimers
1
AgeneBio to Present as a Top Project to Watch: Most Licensable Products in Neuroscience @ TAP Conference https://nitter.cf/t.co/eaaNsJPT8y #Alzheimers
1